Indefinite Delivery Contract SPE2DX16D2903
- Not listed
- The federal contract IDV award is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at up to $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00, enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers the delivery of specialty medications, brand-name and...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 2036. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of a comprehensive range of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00, has an ultimate completion date of December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp delivers a wide variety of essential medical...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
- The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at $999,999,999. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at up to $4,999,999.00, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, which has an ultimate completion date of November 23, 2023, is focused on providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a wide...
- The federal contract IDV award is an Indefinite Delivery Contract (IDC) with a ceiling value of $4,999,999.99, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, which runs through December 31, 2025, is a single-award vehicle that enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contracted...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at up to $4,999,999.99, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and runs through December 31, 2025. Under this IDC, Amerisourcebergen Drug Corp is the prime contractor responsible for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains such as cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care. The contract does not have any set-aside requirements, indicating open competition. In addition to the DLA IDC, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/2/16 |